| Women (n = 61) | Men (n = 19) |
---|---|---|
Age, years | 60.8 (57.3 to 64.4) | 63.4 (59.8 to 66.9) |
Disease duration, yearsa | 6.0 (2.0 to 15.0) | 5.0 (3.0 to 9.0) |
Rheumatoid factor positive, N (%) | 51 (84) | 14 (74) |
Erosive disease, N (%) | 47 (77) | 14 (74) |
ESR, mm/ha | 16.0 (9.0 to 29.0) | 12.0 (9.0 to 15.0) |
C-reactive protein, mg/la | 2.0 (1.0 to 8.0) | 3.0 (1.0 to 9.0) |
DAS28 | 3.3 (3.0 to 3.6) | 2.6 (2.1 to 3.0) |
HAQ score (0 to 3) | 0.7 (0.5 to 0.8) | 0.5 (0.2 to 0.7) |
Patients on DMARDs, N (%) | 59 (97) | 19 (100) |
Patients on glucocorticoids, N (%) | 17 (28) | 3 (16) |
Glucocorticoids, dose, mg | 4.3 (3.4 to 5.3) | 4.2 (0.6 to 7.8) |
Hypertension, N (%) | 33 (54) | 13 (68) |
MetS, N (%) | 12 (20) | 12 (63) |